Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Recruitment Status

Completed clinical trials

Status pages show live ClinicalTrials.gov search results by recruitment status, with direct links to official study records plus page-level filtering and sorting.

ClinicalTrials.gov public records Last synced Jun 19, 2026, 4:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials
31388
Shown on this page
12
Local top conditions
6
Local top sponsors
6
The trial list below is retrieved from the live ClinicalTrials.gov search API for status Completed. Results on this page are currently sorted by Recently updated.

Filter and sort this status page

These controls apply only within Completed. Default order is Recently updated. Add condition, location, sponsor, or therapy filters to narrow this status page further.

Reset status filters
Clear filters
Showing 1–12 of 31,388 matching trials with status Completed.
Indexed local directory records.

Top conditions

Breast Cancer 846 Lymphoma 562 Obesity 539 Healthy 538 HIV Infections 493 Leukemia 493

Top sponsors

National Cancer Institute (NCI) 897 M.D. Anderson Cancer Center 460 National Institute of Allergy and Infectious Diseases (NIAID) 432 Mayo Clinic 415 Pfizer 400 Memorial Sloan Kettering Cancer Center 397

Top locations

New York, New York 5139 Houston, Texas 4503 Boston, Massachusetts 4459 Chicago, Illinois 3659 Los Angeles, California 3507 Philadelphia, Pennsylvania 3433

Top therapies

cyclophosphamide 343 Cyclophosphamide 287 radiation therapy 285 filgrastim 266 Carboplatin 231 Paclitaxel 204

Indexed official records

Open in full search
Completed Not applicable Interventional Accepts healthy volunteers

Aspire2B Personalization Pilot Study Program

NCT06191822
View directory record Official record
Conditions
App Proficiency, Behavior, Lifestyle
Interventions
Fitness, Nutrition, Sleep
Other
Lead sponsor
PepsiCo Global R&D
Industry
Eligibility
18 Years to 75 Years
Enrollment
1,714 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2023
U.S. locations
1
States / cities
Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated Jun 4, 2026 · Synced Jun 7, 2026, 4:29 AM EDT
Completed Phase 2 Interventional Results available

Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT03691714
View directory record Official record
Conditions
Head and Neck Cancer, Head and Neck Neoplasms, Metastatic Cancer, Recurrent Head and Neck Cancer
Interventions
Cetuximab, Durvalumab
Drug
Lead sponsor
Trisha Wise-Draper
Other
Eligibility
18 Years and older
Enrollment
35 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2024
U.S. locations
1
States / cities
Cincinnati, Ohio
Source: ClinicalTrials.gov public record
Updated May 31, 2026 · Synced Jun 17, 2026, 6:01 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

A Novel Interruption Management Intervention for New Graduate Nurses During Medication Administration

NCT07599215
View directory record Official record
Conditions
Career Mobility, Education Nursing, Nurses, Simulation Based Learning
Interventions
Experimental: Stay S.A.F.E. Interruption Management Education, Medication Safety Education
Other
Lead sponsor
Baystate Medical Center
Other
Eligibility
Not listed
Enrollment
56 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024
U.S. locations
1
States / cities
Springfield, Massachusetts
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 21, 2026, 2:23 AM EDT
Completed No phase listed Observational

Acute MI Staging Diagnosis by High-sensitivity Cardiac Troponin-I

NCT07163988
View directory record Official record
Conditions
Acute Myocardial Infarction (AMI)
Interventions
Not listed
Lead sponsor
Rohan Dharmakumar
Other
Eligibility
18 Years to 79 Years
Enrollment
312 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2025
U.S. locations
1
States / cities
Indianapolis, Indiana
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 20, 2026, 1:10 PM EDT
Completed Phase 2 Interventional

A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension

NCT06608901
View directory record Official record
Conditions
Sepsis-Induced Hypotension
Interventions
PB, REGN7544
Drug
Lead sponsor
Regeneron Pharmaceuticals
Industry
Eligibility
18 Years to 85 Years
Enrollment
76 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2026
U.S. locations
16
States / cities
Tucson, Arizona • New Haven, Connecticut • Atlanta, Georgia + 10 more
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 20, 2026, 1:27 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Expansion of the T1DES Pilot to a Public Hospital

NCT06494722
View directory record Official record
Conditions
Type 1 Diabetes
Interventions
Diabetes Education, T1DES
Behavioral
Lead sponsor
Kaiser Permanente
Other
Eligibility
18 Years to 30 Years
Enrollment
42 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2026
U.S. locations
1
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 21, 2026, 2:23 AM EDT
Completed Not applicable Interventional

Physical Activity Centers Empowerment

NCT06411756
View directory record Official record
Conditions
Colorectal Neoplasms
Interventions
A Fitbit activity tracker, Daily text message, Monthly Zoom meeting, Narrative videos, Printed materials, Printed materials, Website access
Behavioral · Other
Lead sponsor
UNC Lineberger Comprehensive Cancer Center
Other
Eligibility
18 Years and older
Enrollment
21 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2026
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 21, 2026, 1:52 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Parenting Support for Justice Involved Families

NCT06329336
View directory record Official record
Conditions
Mental Health Wellness 1, Parenting, Well-Being, Psychological
Interventions
Social Emotional Competence for Children and Parents
Behavioral
Lead sponsor
University of Washington
Other
Eligibility
18 Years and older
Enrollment
13 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2025
U.S. locations
1
States / cities
Seattle, Washington
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 20, 2026, 10:46 AM EDT
Completed Phase 3 Interventional

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

NCT06267560
View directory record Official record
Conditions
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Interventions
Placebo, TQJ230
Drug
Lead sponsor
Novartis Pharmaceuticals
Industry
Eligibility
18 Years to 80 Years
Enrollment
422 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2026
U.S. locations
89
States / cities
Birmingham, Alabama • Little Rock, Arkansas • Beverly Hills, California + 69 more
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 20, 2026, 11:43 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Game-Based Intervention to Promote HPV Vaccination

NCT06162676
View directory record Official record
Conditions
HPV Infection, Vaccine-Preventable Diseases
Interventions
HPV game
Behavioral
Lead sponsor
Michigan State University
Other
Eligibility
11 Years to 14 Years
Enrollment
133 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2026
U.S. locations
1
States / cities
East Lansing, Michigan
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 20, 2026, 8:44 AM EDT
Completed Phase 2 Interventional Results available

Identification of Nerves Using Fluorescein Sodium

NCT06054178
View directory record Official record
Conditions
Head and Neck, Head and Neck Disorder, Pleomorphic Adenoma of the Parotid, Thyroid Disease, Thyroidectomy, Warthin Tumor
Interventions
Fluorescein Sodium
Drug
Lead sponsor
Stanford University
Other
Eligibility
18 Years and older
Enrollment
8 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2025
U.S. locations
1
States / cities
Palo Alto, California
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 20, 2026, 11:57 PM EDT
Completed Phase 1Phase 2 Interventional

LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer

NCT05900986
View directory record Official record
Conditions
Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast
Interventions
LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT 0.075 mg/kg, LS301-IT 0.1 mg/kg
Drug
Lead sponsor
Integro Theranostics
Industry
Eligibility
18 Years to 80 Years · Female only
Enrollment
22 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
9
States / cities
Scottsdale, Arizona • Washington D.C., District of Columbia • Weston, Florida + 6 more
Source: ClinicalTrials.gov public record
Updated May 19, 2026 · Synced May 21, 2026, 1:52 AM EDT